Literature DB >> 8592733

Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction.

L Rønnov-Jessen1, O W Petersen, M J Bissell.   

Abstract

Reciprocal interactions between epithelium and mesenchyme mediate crucial aspects of embryonic development and direct the coordinated organogenesis, correct spatial orientation, and the timely expression of functional activity consistent with physiological demands. The mesenchymal equivalent in the adult organism is the stroma, i.e., the loose connective tissue that is separated from the epithelial compartment by an intact basement membrane. In carcinomas, the cellular organization is dramatically changed, and the stroma is extensively modified. The basement membrane is penetrated in a process of degradation and/or decreased synthesis, and direct contact between tumor cells and the surrounding stroma coincides with neovascularization, inflammatory cell influx, and extensive remodeling of extracellular matrix. In this review, we highlight our current knowledge of tumor cell stromal interactions in the mammary gland with particular emphasis on cellular origins and functional phenotypes. We focus both on normal mammary gland and breast tumors and on culture systems developed to dissect individual aspects of cell-cell and cell-extracellular matrix interactions.

Entities:  

Mesh:

Year:  1996        PMID: 8592733     DOI: 10.1152/physrev.1996.76.1.69

Source DB:  PubMed          Journal:  Physiol Rev        ISSN: 0031-9333            Impact factor:   37.312


  273 in total

1.  Differential expression of SM22 isoforms in myofibroblasts and smooth muscle cells from rabbit bladder.

Authors:  A Chiavegato; M Roelofs; R Franch; E Castellucci; F Sarinella; S Sartore
Journal:  J Muscle Res Cell Motil       Date:  1999-02       Impact factor: 2.698

Review 2.  The mammary fat pad.

Authors:  M C Neville; D Medina; J Monks; R C Hovey
Journal:  J Mammary Gland Biol Neoplasia       Date:  1998-04       Impact factor: 2.673

Review 3.  Structural cues from the tissue microenvironment are essential determinants of the human mammary epithelial cell phenotype.

Authors:  K L Schmeichel; V M Weaver; M J Bissell
Journal:  J Mammary Gland Biol Neoplasia       Date:  1998-04       Impact factor: 2.673

Review 4.  Regulation of mammary gland growth and morphogenesis by the mammary fat pad: a species comparison.

Authors:  R C Hovey; T B McFadden; R M Akers
Journal:  J Mammary Gland Biol Neoplasia       Date:  1999-01       Impact factor: 2.673

Review 5.  Tissue architecture and breast cancer: the role of extracellular matrix and steroid hormones.

Authors:  R K Hansen; M J Bissell
Journal:  Endocr Relat Cancer       Date:  2000-06       Impact factor: 5.678

6.  Isolation, immortalization, and characterization of a human breast epithelial cell line with stem cell properties.

Authors:  Thorarinn Gudjonsson; René Villadsen; Helga Lind Nielsen; Lone Rønnov-Jessen; Mina J Bissell; Ole William Petersen
Journal:  Genes Dev       Date:  2002-03-15       Impact factor: 11.361

Review 7.  Stem cells in the human breast.

Authors:  Ole William Petersen; Kornelia Polyak
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-05       Impact factor: 10.005

8.  Increased proteasome-dependent degradation of estrogen receptor-alpha by TGF-beta1 in breast cancer cell lines.

Authors:  Trevor A Petrel; Robert W Brueggemeier
Journal:  J Cell Biochem       Date:  2003-01-01       Impact factor: 4.429

9.  Differential expression of a chloride intracellular channel gene, CLIC4, in transforming growth factor-beta1-mediated conversion of fibroblasts to myofibroblasts.

Authors:  Lone Rønnov-Jessen; René Villadsen; John C Edwards; Ole W Petersen
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

10.  Wnt1 expression induces short-range and long-range cell recruitments that modify mammary tumor development and are not induced by a cell-autonomous beta-catenin effector.

Authors:  Young Chul Kim; Rod J Clark; Erik A Ranheim; Caroline M Alexander
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.